Wealth Enhancement Advisory Services, LLC Novo Cure LTD Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 26,215 shares of NVCR stock, worth $296,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,215
Previous 11,116
135.83%
Holding current value
$296,753
Previous $143,000
106.99%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVCR
# of Institutions
291Shares Held
74.5MCall Options Held
1.26MPut Options Held
247K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.64MShares$109 Million7.58% of portfolio
-
State Street Corp Boston, MA2.61MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$28 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...